BNTC
Benitec Biopharma Inc.
NASDAQ · Healthcare · Biotechnology · US
$12.68
+1.93%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 11.97x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 2.38x
- Price / sales
- 783.48x
- Price / cash flow
- -21.18x
Enterprise value
- Enterprise value
- $251.7M
- EV / sales
- 452.75x
- EV / EBITDA
- -4.71x
- EV / EBIT
- -4.67x
- Market cap
- $435.6M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Mar 1, 2026